Spotlight
Clinical
CME/CE
Subscribe
- Benign Prostatic Hyperplasia
- Hormone Therapy
- Genomic Testing
- Next-Generation Imaging
- UTUC
- OAB and Incontinence
- Genitourinary Cancers
- Kidney Cancer
- Men's Health
- Pediatrics
- Female Urology
- Sexual Dysfunction
- Kidney Stones
- Urologic Surgery
- Bladder Cancer
- Benign Conditions
- Prostate Cancer
Dr. Schwen on focal therapies for prostate cancer
On an episode of Cleveland Clinic’s Cancer Advances podcast, host Dale Shepard, MD, PhD, talked with Zeyad Schwen, MD, about the use of focal therapy to treat patients with localized prostate cancer.
Schwen, who is a urologic oncologist at Cleveland Clinic, covers these topics:
- The difference between traditional treatments and focal therapies
- Factors that make a patient a good candidate for focal therapy
- Focal procedures, including Nanoknife, high-intensity focused ultrasound and cryotherapy
- Risk of recurrence and salvage therapies
- Clinical trials devoted to focal therapies
Related Videos
Related Content
Cell-cycle risk score is predictive of ADT benefit in prostate cancer
May 17th 2024Article
"Prolaris precisely describes the difference in metastasis outcomes for men receiving monotherapy (RT) vs multimodal therapy (RT+ADT), and further tells me precisely what the risk of death is for a man on surveillance," says Jonathan D. Tward, MD, PhD.
